Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Prasanth Rathinam, Bhasker Mohan Murari & Pragasam Viswanathan. (2021) Biofilm inhibition and antifouling evaluation of sol-gel coated silicone implants with prolonged release of eugenol against Pseudomonas aeruginosa
. Biofouling 37:5, pages 521-537.
Read now
Read now
Sonia Kapoor & Dulal Panda. (2009) Targeting FtsZ for antibacterial therapy: a promising avenue. Expert Opinion on Therapeutic Targets 13:9, pages 1037-1051.
Read now
Read now
Articles from other publishers (34)
Aslihan Ozcan, Ozlem Keskin, Berna Sariyar Akbulut & Pemra Ozbek. (2023) Piperidine-based natural products targeting Type IV pili antivirulence: A computational approach. Journal of Molecular Graphics and Modelling 119, pages 108382.
Crossref
Crossref
Mona H. El-Gayar, Rania A. H. Ishak, Ahmed Esmat, Mohammad M. Aboulwafa & Khaled M. Aboshanab. (2022) Evaluation of lyophilized royal jelly and garlic extract emulgels using a murine model infected with methicillin-resistant Staphylococcus aureus. AMB Express 12:1.
Crossref
Crossref
John H. Bushweller. (2020) Protein Disulfide Exchange by the Intramembrane Enzymes DsbB, DsbD, and CcdA. Journal of Molecular Biology 432:18, pages 5091-5103.
Crossref
Crossref
Shreya Bhattacharya, Puja Ghosh, Debasmita Banerjee, Arundhati Banerjee & Sujay Ray. (2020) In Silico Drug Target Discovery Through Proteome Mining from M. tuberculosis: An Insight into Antivirulent Therapy. Combinatorial Chemistry & High Throughput Screening 23:3, pages 253-268.
Crossref
Crossref
Jitendra Patel, Hsin-Bai Yin, Gary Bauchan & Joseph Mowery. (2020) Inhibition of Escherichia coli O157:H7 and Salmonella enterica virulence factors by benzyl isothiocyanate. Food Microbiology 86, pages 103303.
Crossref
Crossref
Xin Pang, Xue Liu, Yi Cheng, Chang Zhang, En Ren, Chao Liu, Yang Zhang, Jing Zhu, Xiaoyuan Chen & Gang Liu. (2019) Sono‐Immunotherapeutic Nanocapturer to Combat Multidrug‐Resistant Bacterial Infections. Advanced Materials 31:35, pages 1902530.
Crossref
Crossref
Alicia Bravo, Sofia Ruiz-Cruz, Itziar Alkorta & Manuel Espinosa. (2018) When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics. Biomolecular Concepts 9:1, pages 216-226.
Crossref
Crossref
Sung-Min Kang, Do-Hee Kim, Chenglong Jin & Bong-Jin Lee. (2018) A Systematic Overview of Type II and III Toxin-Antitoxin Systems with a Focus on Druggability. Toxins 10:12, pages 515.
Crossref
Crossref
Mona H. El-Gayar, Khaled M. Aboshanab, Mohammad M. Aboulwafa & Nadia A. Hassouna. (2016) Antivirulence and wound healing effects of royal jelly and garlic extract for the control of MRSA skin infections. Wound Medicine 13, pages 18-27.
Crossref
Crossref
E Saleh Sarra, M Aboshanab Khaled, M Aboulwafa Mohammad & A Hassouna Nadia. (2015) Effects of plasmid acquisition by Pseudomonas aeruginosa clinical isolates on methicillin-resistant Staphylococcus aureus biofilm formation. African Journal of Microbiology Research 9:48, pages 2307-2319.
Crossref
Crossref
Wai Ting Chan, Dolors Balsa & Manuel Espinosa. (2015) One cannot rule them all: Are bacterial toxins-antitoxins druggable?. FEMS Microbiology Reviews 39:4, pages 522-540.
Crossref
Crossref
Chun Kiat Ng, Anee Mohanty & Bin Cao. 2015. Bio-Nanoparticles. Bio-Nanoparticles
83
100
.
Dimpy Kalia. 2015. Quorum Sensing vs Quorum Quenching: A Battle with No End in Sight. Quorum Sensing vs Quorum Quenching: A Battle with No End in Sight
285
302
.
Anee Mohanty, Mustafa Hussain Kathawala, Jianhua Zhang, Wei Ning Chen, Joachim Say Chye Loo, Staffan Kjelleberg, Liang Yang & Bin Cao. (2014)
Biogenic tellurium nanorods as a novel antivirulence agent inhibiting pyoverdine production in
Pseudomonas aeruginosa
. Biotechnology and Bioengineering 111:5, pages 858-865.
Crossref
Crossref
Hung The Dang, Erik Chorell, Hanna Uvell, Jerome S. Pinkner, Scott J. Hultgren & Fredrik Almqvist. (2014) Syntheses and biological evaluation of 2-amino-3-acyl-tetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activity. Org. Biomol. Chem. 12:12, pages 1942-1956.
Crossref
Crossref
Wai Ting Chan, Inma Moreno-Córdoba, Chew Chieng Yeo & Manuel Espinosa. (2012) Toxin-Antitoxin Genes of the Gram-Positive Pathogen Streptococcus pneumoniae: So Few and Yet So Many. Microbiology and Molecular Biology Reviews 76:4, pages 773-791.
Crossref
Crossref
S. V. Dentovskaya, A. P. Anisimov, A. N. Kondakova, B. Lindner, O. V. Bystrova, T. E. Svetoch, R. Z. Shaikhutdinova, S. A. Ivanov, I. V. Bakhteeva, G. M. Titareva & Yu. A. Knirel. (2011) Functional characterization and biological significance of Yersinia pestis lipopolysaccharide biosynthesis genes. Biochemistry (Moscow) 76:7, pages 808-822.
Crossref
Crossref
Warren R. J. D. GallowayJames T. HodgkinsonSteven D. BowdenMartin WelchDavid R. Spring. (2010) Quorum Sensing in Gram-Negative Bacteria: Small-Molecule Modulation of AHL and AI-2 Quorum Sensing Pathways. Chemical Reviews 111:1, pages 28-67.
Crossref
Crossref
Manoj Kumar, Farrah G. Khan, Sandeep Sharma, Rajinder Kumar, Jaya Faujdar, Rahul Sharma, Devendra S. Chauhan, Rajinder Singh, Shyam K. Magotra & Inshad A. Khan. (2011) Identification of Mycobacterium tuberculosis genes preferentially expressed during human infection. Microbial Pathogenesis 50:1, pages 31-38.
Crossref
Crossref
Jennifer Campbell. (2010) High-Throughput Assessment of Bacterial Growth Inhibition by Optical Density Measurements. Current Protocols in Chemical Biology 2:4, pages 195-208.
Crossref
Crossref
Maureen T McCann, Brendan F Gilmore & Sean P Gorman. (2008)
Staphylococcus epidermidis
device-related infections: pathogenesis and clinical management
. Journal of Pharmacy and Pharmacology 60:12, pages 1551-1571.
Crossref
Crossref
Nicolas Desroy, François Moreau, Sophia Briet, Géraldine Le Fralliec, Stephanie Floquet, Lionel Durant, Vanida Vongsouthi, Vincent Gerusz, Alexis Denis & Sonia Escaich. (2009) Towards Gram-negative antivirulence drugs: New inhibitors of HldE kinase. Bioorganic & Medicinal Chemistry 17:3, pages 1276-1289.
Crossref
Crossref
Andrey P. Anisimov, Irina V. Bakhteeva, Evgeniy A. Panfertsev, Tat'yana E. Svetoch, Tat'yana B. Kravchenko, Mikhail E. Platonov, Galina M. Titareva, Tat'yana I. Kombarova, Sergey A. Ivanov, Alexander V. Rakin, Kingsley K. Amoako & Svetlana V. Dentovskaya. (2009) The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice. Journal of Medical Microbiology 58:1, pages 26-36.
Crossref
Crossref
Prashant B. Kapadnis, Evan Hall, Madeleine Ramstedt, Warren R. J. D. Galloway, Martin Welch & David R. Spring. (2009) Towards quorum-quenching catalytic antibodies. Chem. Commun.:5, pages 538-540.
Crossref
Crossref
Carmen Giefing, Eszter Nagy & Alexander von Gabain. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
90
117
.
Gabriella Molinari. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
13
27
.
Lynette Cegelski, Garland R. Marshall, Gary R. Eldridge & Scott J. Hultgren. (2008) The biology and future prospects of antivirulence therapies. Nature Reviews Microbiology 6:1, pages 17-27.
Crossref
Crossref
Julian A. Ferreras, Karen L. Stirrett, Xuequan Lu, Jae-Sang Ryu, Clifford E. Soll, Derek S. Tan & Luis E.N. Quadri. (2008) Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation. Chemistry & Biology 15:1, pages 51-61.
Crossref
Crossref
Andrey P. Anisimov & Kingsley K. Amoako. (2006) Treatment of plague: promising alternatives to antibiotics. Journal of Medical Microbiology 55:11, pages 1461-1475.
Crossref
Crossref
Helena I.M. Boshoff & Ujjini H. Manjunatha. (2006) The impact of genomics on discovering drugs against infectious diseases. Microbes and Infection 8:6, pages 1654-1661.
Crossref
Crossref
John J. Barker. (2006) Antibacterial drug discovery and structure-based design. Drug Discovery Today 11:9-10, pages 391-404.
Crossref
Crossref
Prathiba Kurupati, Boon King Teh, Gamini Kumarasinghe & Chit Laa Poh. (2006) Identification of vaccine candidate antigens of an ESBL producingKlebsiella pneumoniae clinical strain by immunoproteome analysis. PROTEOMICS 6:3, pages 836-844.
Crossref
Crossref
John F Barrett. (2005) Adjunct antimicrobial therapy – prospects for the future. Therapy 2:1, pages 67-76.
Crossref
Crossref
John F Barrett. (2005) Adjunct antimicrobial therapy - prospects for the future. Therapy 2:1, pages 67-76.
Crossref
Crossref